Charles Semba (仙波), Md

Charles Semba (仙波), Md Email and Phone Number

Chief Medical Officer and Board Member. Developing global innovative therapeutics for dermal aesthetics and vision-threatening diseases. Look better. See better. @ Eluminex Biosciences Limited
Charles Semba (仙波), Md's Location
South San Francisco, California, United States, United States
About Charles Semba (仙波), Md

+20 years in therapeutic product development in public (Genentech, Shire/Takeda) and private companies (SARcode Biosciences, ForSight VISION5, Graybug Vision); small molecules, biologics, sustained-release, drug delivery; ocular surface, glaucoma, retinal diseases and collagen-based medical devices..

Charles Semba (仙波), Md's Current Company Details
Eluminex Biosciences Limited

Eluminex Biosciences Limited

View
Chief Medical Officer and Board Member. Developing global innovative therapeutics for dermal aesthetics and vision-threatening diseases. Look better. See better.
Charles Semba (仙波), Md Work Experience Details
  • Eluminex Biosciences Limited
    Chief Medical Officer
    Eluminex Biosciences Limited Jun 2020 - Present
    Suzhou, Cn
    Eluminex Biosciences is a privately-held clinical-stage biotechnology company focused on both global and regional development and commercialization of innovative therapeutics to fulfill unmet medical needs in the treatment and management of vision-threatening diseases.
  • Diamedica Therapeutics Inc.
    Board Member
    Diamedica Therapeutics Inc. Jul 2021 - Present
    Minneapolis, Mn, Us
    DiaMedica Therapeutics is a clinical-stage biopharmaceutical company committed to changing the treatment paradigm for acute ischemic stroke (AIS) and chronic kidney disease (CKD). DiaMedica’s lead candidate DM199 is the first pharmaceutically active recombinant (synthetic) form of the KLK1 protein, an established therapeutic modality for the treatment of acute ischemic stroke and chronic kidney disease.
  • Stanford University School Of Medicine
    Adjunct Professor - Vascular And Interventional Radiology
    Stanford University School Of Medicine 1992 - Present
    Palo Alto, Ca, Us
    Development of minimally invasive endovascular treatments for venous disease and complex aortic dissection and thoracic aneurysm repair. Fellowship Program Director.
  • Graybug Vision, Inc.
    Chief Medical Officer
    Graybug Vision, Inc. Jun 2016 - Mar 2020
    Graybug is a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve.
  • Forsight Vision5, Inc.
    Chief Medical Officer
    Forsight Vision5, Inc. Jun 2014 - Jun 2016
    (Acquired by Allergan for $95M plus milestones) Sustained-delivery of bimatoprost using a novel ocular insert for the treatment of glaucoma/ocular hypertension. Phase 1, 2 development programs and Phase 3 planning. Development of fixed combination (bimatoprost/timolol) ocular insert for glaucoma/ocular hypertension.
  • Shire
    Vice President - Clinical Medicine (Ophthalmology)
    Shire Apr 2013 - Jun 2014
    Tokyo, Jp, Jp
    Global clinical development lead for Xiidra (lifitegrast ophthalmic solution) for dry eye disease (acquired from SARcode Bioscience). Approved by FDA July 2016.
  • Sarcode Bioscience, Inc.
    Chief Medical Officer
    Sarcode Bioscience, Inc. Nov 2007 - Apr 2013
    Brisbane, California, Us
    (Acquired by Shire for $160M plus future milestones). Development of lifitegrast ophthalmic solution for dry eye disease. IND filing through NDA.
  • Genentech
    Senior Group Director - Division Of Tissue Growth And Repair
    Genentech 2000 - 2007
    South San Francisco, California, Us
    Clinical development team leader for ranibizumab (Lucentis), Phase 1b through BLA-filing and FDA approval (June 2006); neovascular age-related macular degeneration(AMD), diabetic macular edema (DME), retinal vein occlusion (RVO). Cardiovascular medicine - clinical lead sBLA TNKase (tenecteplase) approval - acute myocardial infarction, sBLA Activase approval (alteplase) - acute ischemic stroke, sBLA approval CathFlo Activase (alteplase) - restoration of function to central venous access devices.

Charles Semba (仙波), Md Skills

Biotechnology Clinical Trials Drug Development Clinical Development Pharmaceutical Industry Immunology Biopharmaceuticals Medical Devices Clinical Research Medicine Ophthalmology Life Sciences Fda Endocrinology Product Launch Medical Affairs Lifesciences Gcp Drug Discovery Regulatory Submissions Commercialization Therapeutic Areas Molecular Biology R&d Regulatory Affairs Pharmacovigilance Medical Imaging Protocol U.s. Food And Drug Administration Good Clinical Practice Research And Development

Charles Semba (仙波), Md Education Details

  • Uc San Diego
    Uc San Diego
    Diagnostic Radiology
  • Miami Cardiac & Vascular Institute
    Miami Cardiac & Vascular Institute
    Vascular And Interventional Radiology
  • University Of Minnesota Medical School
    University Of Minnesota Medical School
    Md
  • Carleton College
    Carleton College
    Chemistry

Frequently Asked Questions about Charles Semba (仙波), Md

What company does Charles Semba (仙波), Md work for?

Charles Semba (仙波), Md works for Eluminex Biosciences Limited

What is Charles Semba (仙波), Md's role at the current company?

Charles Semba (仙波), Md's current role is Chief Medical Officer and Board Member. Developing global innovative therapeutics for dermal aesthetics and vision-threatening diseases. Look better. See better..

What is Charles Semba (仙波), Md's email address?

Charles Semba (仙波), Md's email address is cp****@****ode.com

What is Charles Semba (仙波), Md's direct phone number?

Charles Semba (仙波), Md's direct phone number is +165064*****

What schools did Charles Semba (仙波), Md attend?

Charles Semba (仙波), Md attended Uc San Diego, Miami Cardiac & Vascular Institute, University Of Minnesota Medical School, Carleton College.

What are some of Charles Semba (仙波), Md's interests?

Charles Semba (仙波), Md has interest in Christianity, Kids, Cooking, Electronics, Outdoors, Home Improvement, Donor, Shooting, Gourmet Cooking, Sports.

What skills is Charles Semba (仙波), Md known for?

Charles Semba (仙波), Md has skills like Biotechnology, Clinical Trials, Drug Development, Clinical Development, Pharmaceutical Industry, Immunology, Biopharmaceuticals, Medical Devices, Clinical Research, Medicine, Ophthalmology, Life Sciences.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.